ANTHELIOS 20 Drug Patent Profile
✉ Email this page to a colleague
When do Anthelios 20 patents expire, and when can generic versions of Anthelios 20 launch?
Anthelios 20 is a drug marketed by Loreal Usa and is included in one NDA.
The generic ingredient in ANTHELIOS 20 is avobenzone; ecamsule; octocrylene; titanium dioxide. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene; titanium dioxide profile page.
Summary for ANTHELIOS 20
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANTHELIOS 20 at DailyMed |
Recent Clinical Trials for ANTHELIOS 20
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Loreal USA | Phase 4 |
US Patents and Regulatory Information for ANTHELIOS 20
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loreal Usa | ANTHELIOS 20 | avobenzone; ecamsule; octocrylene; titanium dioxide | CREAM;TOPICAL | 021471-001 | Oct 5, 2006 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |